The pneumococcal vaccine is linked with a 62 percent decrease in antibiotic-resistant cases of pneumococcal infections.
This vaccine is an important step in preventing the spread of antibiotic-resistant superbugs.
The pneumococcal vaccine is recommended for children under five years old, adults 65 or older, or people with health conditions that put them at a higher risk.